Table 2. Patient clinical parameters according to their molecular response to 400 mg imanitib daily.
Variable | CMR (n=28) | No CMR (n=8) | P value |
---|---|---|---|
Imatinib plasma trough concentrations (ng/mL) | 1263.39±532.55 | 1543.38±734.11 | 0.237 |
Age (years) | 38.39±12.35 | 39.38±14.18 | 0.849 |
Weight (kg) | 62.54±9.72 | 58.75±12.17 | 0.365 |
BSA (m2) | 1.67±0.14 | 1.61±0.18 | 0.338 |
Time elapsed (months) | 20.57±17.21 | 39.38±23.11 | 0.016 |
Duration (months) | 30.14±13.86 | 24.88±20.50 | 0.401 |